Identification | Back Directory | [Name]
(S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid | [CAS]
254750-02-2 | [Synonyms]
CS-1040 CS-2634 IDN 6556 EMricasan abs816139 PF 03491390 Emricasan, (IDN-6556 Emricasan, PF 03491390 Emricasan(IDN6556,PF03491390) IDN-6556;PF-03491390;PF03491390 (S)-3-((S)-2-(2-(2-tert-butylphenylaMino)-2-oxoacetaMido)propana IDN 6556; PF 03491390; PF03491390; PF-03491390; IDN-6556;IDN6556;PF03491390 (S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tet (S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetraf (3S)-3-[(N-{[(2-tert-butylphenyl)amino](oxo)acetyl}-L-alanyl)amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid N-[2-(tert-butyl)phenyl]-2-oxoglycyl-N-[(1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]-L-alaninamide (S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid N-[2-(1,1-Dimethylethyl)phenyl]-2-oxoglycyl-N-[(1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]-L-alaninamide L-Alaninamide, N-[2-(1,1-dimethylethyl)phenyl]-2-oxoglycyl-N-[(1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]- (S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid USP/EP/BP EMricasan
(S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid | [Molecular Formula]
C26H27F4NO7 | [MDL Number]
MFCD11840420 | [MOL File]
254750-02-2.mol | [Molecular Weight]
569.502 |
Chemical Properties | Back Directory | [density ]
1.386 | [storage temp. ]
-20°C | [solubility ]
DMSO:42.0(Max Conc. mg/mL);73.75(Max Conc. mM) Ethanol:100.0(Max Conc. mg/mL);175.59(Max Conc. mM) | [form ]
powder | [pka]
3.91±0.19(Predicted) | [color ]
white to beige | [CAS DataBase Reference]
254750-02-2 |
Hazard Information | Back Directory | [Uses]
Emricasan is an irreversible pan-caspase inhibitor that hinders caspase-mediated apoptosis and inflammation.?In addition, Emricasan may reduce hepatic injury and liver fibrosis. | [storage]
Store at -20°C |
|
|